Header Logo

Connection

RAYNE ROUCE to Neoplasms

Back to Details
This is a "connection" page, showing publications RAYNE ROUCE has written about Neoplasms.
RAYNE ROUCE
Connection Strength
0.450
Neoplasms
  1. New models for the development of and access to CAR T-cell therapies for children and adolescents with cancer: an ACCELERATE multistakeholder analysis. Lancet Oncol. 2025 Apr; 26(4):e214-e224.
    View in: PubMed
    Score: 0.086
  2. Cardiovascular Complications of Immune Effector Cell Therapies in Pediatric Hematological and Solid Tumors. Pediatr Blood Cancer. 2025 Apr; 72(4):e31557.
    View in: PubMed
    Score: 0.085
  3. Cell and gene therapy accessibility. Science. 2024 08 02; 385(6708):475.
    View in: PubMed
    Score: 0.083
  4. Apoptosis of Hematopoietic Stem Cells Contributes to Bone Marrow Suppression Following Chimeric Antigen Receptor T Cell Therapy. Transplant Cell Ther. 2023 03; 29(3):165.e1-165.e7.
    View in: PubMed
    Score: 0.074
  5. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24.
    View in: PubMed
    Score: 0.072
  6. Engineering Natural Killer Cells for Cancer Immunotherapy. Mol Ther. 2017 08 02; 25(8):1769-1781.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.